Repligen
RGEN
#2768
Rank
A$8.60 B
Marketcap
A$152.62
Share price
4.23%
Change (1 day)
-21.92%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): A$0.12 Billion

According to Repligen 's latest financial reports the company's current earnings are A$0.73 Billion. , an increase over its 2024 earnings that were of -A$8.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 A$0.11 B-1430.84%
2024 -A$8.86 Million-113.01%
2023 A$68.08 M-78.01%
2022 A$0.30 B33.37%
2021 A$0.23 B131.52%
2020 A$0.10 B101.31%
2019 A$49.8 M25.93%
2018 A$39.55 M105.61%
2017 A$19.23 M-11.46%
2016 A$21.72 M14.91%
2015 A$18.9 M20.26%
2014 A$15.72 M-51.49%
2013 A$32.4 M90.98%
2012 A$16.97 M
2010 A$0.24 M-103.81%
2009 -A$6.45 Million-223.84%
2008 A$5.2 M
2006 -A$3.5 Million229.64%
2005 -A$1.07 Million-89.16%
2004 -A$9.79 Million-16.86%
2003 -A$11.78 Million88.72%
2002 -A$6.24 Million-27.88%
2001 -A$8.65 Million-1.74%
2000 -A$8.81 Million85.93%
1999 -A$4.74 Million159.16%
1998 -A$1.83 Million85.71%
1997 -A$0.99 Million-70.83%
1996 -A$3.38 Million-72.41%
1995 -A$12.23 Million-60.63%
1994 -A$31.06 Million45.39%
1993 -A$21.36 Million39.45%
1992 -A$15.32 Million-32.3%
1991 -A$22.63 Million6.62%
1990 -A$21.22 Million1577.78%
1989 -A$1.27 Million-57.14%
1988 -A$2.96 Million-362.5%
1987 A$1.12 M-130.77%
1986 -A$3.66 Million136.36%
1985 -A$1.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.88 B 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$10.42 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$15.43 B 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.48 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$0.65 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.12 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$0.14 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA